The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Upstaging and risk migration with blue light cystoscopy for non–muscle-invasive bladder cancer: Results from a prospective multi-center registry.
 
Alireza Ghoreifi
No Relationships to Disclose
 
Badrinath Konety
Stock and Other Ownership Interests - Astrin Biosciences; Styx Biotechnologies
Consulting or Advisory Role - Abbott Inc; Asieris Pharmaceuticals
Research Funding - BMSi (Inst); Pacific Edge Biotechnology (Inst)
Travel, Accommodations, Expenses - Asieris Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Styx Biotechnologies
 
Kamal Pohar
No Relationships to Disclose
 
Jeffrey Holzbeierlein
Stock and Other Ownership Interests - MoKan Laboratories LLC
Consulting or Advisory Role - Basilea; KDx Diagnostics
Research Funding - MDxHealth (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Medivation
 
John Taylor
No Relationships to Disclose
 
Max Kates
No Relationships to Disclose
 
Brian Willard
Speakers' Bureau - Photocure
Research Funding - Photocure
 
Jennifer Taylor
No Relationships to Disclose
 
Joseph Liao
No Relationships to Disclose
 
Hristos Kaimakliotis
No Relationships to Disclose
 
Sima Porten
Honoraria - American Urologic Association; Exact Sciences; Pacific Edge
Consulting or Advisory Role - AstraZeneca; Oncuria; Photocure; Stryker
Research Funding - Photocure (Inst)
 
Gary Steinberg
Stock and Other Ownership Interests - CG Oncology; enGene; Epivax Therapeutics
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Asieris Pharmaceuticals; AstraZeneca; Aura Biosciences; Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; Imvax; MDxHealth; Merck; NanOlogy; Natera; Nonagen Bioscience; photocure; Roche/Genentech; Taris BioMedical; Verity Pharmaceuticals
 
Mark Tyson
Consulting or Advisory Role - AstraZeneca; enGene; ImmunityBio
Research Funding - AstraZeneca (Inst); CG Oncology (Inst); enGene (Inst); Ferring (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); NCI (Inst); pacific edge (Inst); Protara Therapeutics (Inst); Seagen (Inst); SWOG (Inst); Urogen pharma (Inst)
 
Yair Lotan
Consulting or Advisory Role - Photocure
Other Relationship - Storz
 
Siamak Daneshmand
Consulting or Advisory Role - Carl Storz; Ferring; Janssen; pacific edge; Photocure; Protara Therapeutics; Sasen; UROGENE
Speakers' Bureau - Pfizer
Other Relationship - Johnson & Johnson